~~<i id='6287C74A22'><strike id='6287C74A22'><tt id='6287C74A22'><pre id='6287C74A22'></pre></tt></strike></i>~~

Home» Wikipedia» comprehensive

comprehensive

author：entertainment 2025-09-30 07:41:07 Page View：845

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says
Next article： Activists slam private health insurers over coverage restrictions

explore

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

2:42PresidentJoeBidenspeaksintheEastRoomoftheWhiteHouseinWashington,July25,2023.SusanWalsh/APPreside

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

MollyFergusonforSTATThenewsthattheweightlossdrugWegovyreducedtheriskofheartattacksandstrokesinoverwe